Pfizer is a highly respected drug company facing normal industry headwinds.
Pfizer's dividend yield is 7% for a very good reason: investors are worried about the risk of a dividend cut.
It is definitely a strong contender.
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging ...
Pfizer has reached agreements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla, regarding lawsuits filed in the U.S. District Court for the District of Delaware. Vyndamax remains the market leader ...
June 24 (Reuters) - Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit in which most U.S. states accused dozens of drugmakers and executives of fixing prices of generic drugs, ...
Pfizer announced yesterday it was settling an epic legal battle with the Indian drugmaker Ranbaxy Laboratories that will keep generic versions of the best-selling cholesterol medicine Lipitor off the ...
By Jonathan Stempel June 24 (Reuters) - Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit in which most U.S. states accused dozens of drugmakers and executives of fixing prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results